Expression of neuroblastoma-related genes in bone marrow at end of high-risk neuroblastoma therapy.

Shahab AsgharzadehAraz Marachelian Judith G VillablancaWei Yao LiuRebekah KennedyRichard SpostoArlene NaranjoSheena TenneyAlice L YuM Fevzi OzkaynakPaul M SondelJulie R ParkRobert C Seeger

Published in: Pediatric blood & cancer (2022)

If further validated in additional patient cohorts, the NB5 assay's ability to independently predict EFS from end-therapy could improve patient stratification for novel maintenance therapy trials after current end-therapy to improve outcome.

Keyphrases

case report
mesenchymal stem cells
poor prognosis
stem cells
cell therapy
long non coding rna
binding protein